secwatch.observer — SEC 8-K summary
======================================

Issuer:     GoodRx Holdings, Inc. (GDRX)
CIK:        0001809519
Form:       8-K
Filed at:   2025-12-12T23:59:59+00:00
Accession:  0001809519-25-000156
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GoodRx grants $3M retention bonuses to CEO and CFO
--------------------------------------------------

- CEO Wendy Barnes receives $2M retention bonus; CFO Chris McGinnis receives $1M.
- Bonuses payable within 15 days of Dec 9, 2025 execution; subject to clawback if employment ends for cause or without good reason before Dec 31, 2027.
- Full after-tax repayment if termination before Dec 31, 2026; 50% if between Jan 1, 2027 and Dec 31, 2027.
- Executives waive participation in 2025 executive bonus plan and any annual incentive program for 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1809519/000180951925000156/0001809519-25-000156-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1809519/000180951925000156/gdrx-20251209.htm
  HTML page:      https://secwatch.observer/filing/0001809519-25-000156

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer